ELAB

Elevai Labs (ELAB)

Elevai Labs Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:ELAB

일자	시간	출처	헤드라인	심볼	기업
2024/05/16	05:30	GlobeNewswire Inc.	Elevai Labs Inc. Reports First Quarter 2024 Financial Results	NASDAQ:ELAB	Elevai Labs Inc
2024/05/16	05:02	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ELAB	Elevai Labs Inc
2024/05/10	05:01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ELAB	Elevai Labs Inc
2024/05/02	21:30	GlobeNewswire Inc.	Elevai Biosciences Highlights Preclinical Data Showing Potential of In-Licensed Asset “EL-22” for The Treatment of Obesity	NASDAQ:ELAB	Elevai Labs Inc
2024/05/02	05:00	GlobeNewswire Inc.	Elevai Labs Expands with Launch of Elevai Biosciences and Elevai Skincare Subsidiaries, Advancing the Future of Aesthetic Medicines and Exosome Skincare	NASDAQ:ELAB	Elevai Labs Inc
2024/05/01	22:00	GlobeNewswire Inc.	Elevai Labs Acquires Exclusive License to Two Myostatin Muscle Loss Prevention Assets with Plan to Develop in Combination with GLP-1 Obesity Treatments	NASDAQ:ELAB	Elevai Labs Inc
2024/04/29	22:45	GlobeNewswire Inc.	Elevai Labs Highlights Global Distribution Partnership Overview: Contracts May Secure $4.9M Top Line Revenue Commitments	NASDAQ:ELAB	Elevai Labs Inc
2024/04/22	21:00	GlobeNewswire Inc.	ELEVAI Labs Enters the Taiwan Market with Signing of 5th International Distribution Agreement in 14 Months	NASDAQ:ELAB	Elevai Labs Inc
2024/03/30	01:00	GlobeNewswire Inc.	Elevai Labs Inc. Reports Record Full Year 2023 and Fourth Quarter Financial Results	NASDAQ:ELAB	Elevai Labs Inc
2024/03/18	21:51	InvestorsHub NewsWire	Elevai Labs Launches E-commerce Portal to Support Rapid Growth as Stem Cell Exosome Disruptor in the $19.7 Billion Global Physician Dispensed Cosmeceutical Market	NASDAQ:ELAB	Elevai Labs Inc
2024/01/24	22:30	GlobeNewswire Inc.	ELEVAI Labs Inc. Announces Issuance of Patent from U.S. Patent & Trademark Office	NASDAQ:ELAB	Elevai Labs Inc
2024/01/17	23:07	InvestorsHub NewsWire	ELEVAI LABS, Inc. Reports Strong Preliminary Unaudited Financial Performance for Fiscal Year 2023, Highlighting Significant Revenue Growth and Expanding Global Reach	NASDAQ:ELAB	Elevai Labs Inc
2024/01/17	22:30	GlobeNewswire Inc.	ELEVAI LABS, Inc. Reports Strong Preliminary Unaudited Financial Performance for Fiscal Year 2023, Highlighting Significant Revenue Growth and Expanding Global Reach	NASDAQ:ELAB	Elevai Labs Inc
2024/01/17	00:05	InvestorsHub NewsWire	ELEVAI Labs, Inc. Acquires Worldwide License Agreement for Proprietary Stem Cell Manufacturing Technology	NASDAQ:ELAB	Elevai Labs Inc
2024/01/16	22:30	GlobeNewswire Inc.	ELEVAI Labs, Inc. Acquires Worldwide License Agreement for Proprietary Stem Cell Manufacturing Technology	NASDAQ:ELAB	Elevai Labs Inc
2024/01/02	23:15	GlobeNewswire Inc.	ELEVAI LABS, Inc. to Participate in Upcoming Aesthetic Industry Conferences	NASDAQ:ELAB	Elevai Labs Inc
2023/12/11	23:15	GlobeNewswire Inc.	Elevai Labs Inc Announces Financial Results for the Quarter Ended September 30, 2023	NASDAQ:ELAB	Elevai Labs Inc
2023/12/07	23:41	GlobeNewswire Inc.	ELEVAI Labs, Inc. Expands International Distribution into Europe	NASDAQ:ELAB	Elevai Labs Inc
2023/11/29	23:00	GlobeNewswire Inc.	Elevai Labs Enters into Licensing Agreement with Yuva Biosciences to Combine Exosome and Mitochondrial Technologies to Develop New Aesthetics Products	NASDAQ:ELAB	Elevai Labs Inc
2023/11/25	03:38	PR Newswire (US)	ELEVAI Labs, Inc. Announces Closing of $6,000,000 Initial Public Offering	NASDAQ:ELAB	Elevai Labs Inc
2023/11/25	02:00	GlobeNewswire Inc.	Univest Securities, LLC Announces Closing of $6 Million Initial Public Offering of Common Stock for its Client ELEVAI Labs Inc. (Nasdaq: ELAB)	NASDAQ:ELAB	Elevai Labs Inc
2005/06/24	06:13	Business Wire	Eon Labs Receives Final Approval for Bupropion HCl, ER 200mg Tablets and Will Begin Shipping Immediately	NASDAQ:ELAB	Elevai Labs Inc
2005/06/14	06:41	Business Wire	Appeals Court Affirms that Eon Labs' Itraconazole Does Not Infringe Janssen's Patent	NASDAQ:ELAB	Elevai Labs Inc
2004/02/25	04:34	PR Newswire (US)	Pacific Exchange to Trade Six New Options	NASDAQ:ELAB	Elevai Labs Inc